Scheduled surgical patients for general anesthesia, who are ASA PS I-II, intubation, supine position. Exclusion cases
Conditions
Interventions
Intervention type:DRUG
Name of intervention:remifentanil
Dose form / Japanese Medical Device Nomenclature:INJECTION
Route of administration / Site of application:INTRAVENOUS DRIP
Dose per administrati
Sponsors
Shunji Kobayashi, M.D., PhD
Department of Anesthesiology, Rinku General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Scheduled surgical patients for general anesthesia, who are ASA PS I-II, intubation, supine position.
Exclusion criteria
Exclusion criteria: BMI>30, Age>70, Base line HR180
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent decrease from baseline of SBP, DBP, MBP, and HR | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of treatments of phenylephrine, atropine, and other treatments | — |
Countries
Japan
Contacts
Public ContactShunji Kobayashi, M.D., PhD
Rinku General Hospital
Outcome results
None listed